Express News | EFFECTOR Therapeutics Inc: Terminated Its Controlled Equity Offering Sales Agreement, Dated Sept 1, 2022, With Cantor Fitzgerald & Co

ReutersMay 9 16:54 ET

Express News | EFFECTOR Therapeutics: Under Agreement, Co May, From Time to Time, Sell Shares of Co's Common Stock Having Offering Price of up to $50 Mln

ReutersMay 9 16:53 ET

Express News | EFFECTOR Therapeutics Inc: Entered Into an at the Market Offering Agreement With H.c. Wainwright & Co., LLC

ReutersMay 9 16:53 ET

EFFECTOR Therapeutics Q1 2024 GAAP EPS $(2.16) Beats $(2.17) Estimate; Reports Cash Runway Into Q1 Of 2025

eFFECTOR Therapeutics (NASDAQ:EFTR) reported quarterly losses of $(2.16) per share which beat the analyst consensus estimate of $(2.17) by 0.46 percent.

BenzingaMay 9 16:51 ET

12 Health Care Stocks Moving In Thursday's After-Market Session

GainersSensus Healthcare (NASDAQ:SRTS) shares increased by 33.3% to $5.08 during Thursday's after-market session. The market value of their outstanding shares is at $83.2 million. As per the news, the

BenzingaMay 9 16:31 ET

10-Q: Quarterly report

Futu NewsMay 9 16:10 ET · Announcements